TREM2: A booster against Alzheimer's?
A protein may hold potential starting points for a therapy against Alzheimer's disease. The current finding is that the higher the TREM2 level, the better the…
Amyloid: the trigger of a lethal cascade leading to nerve cell death
In Alzheimer's patients, clumps of amyloid form in the brain long before the first symptoms appear. They play a central role in…
Project overview
Duration: 2023 - 2024 Funding: Bundesministerium für Familie, Senioren, Frauen und Jugend (BMFSFJ) Project Management and Coordination: Dr.…
Fundamental Research
What happens at the molecular level when a person develops a neurodegenerative disease - this question is the focus of basic research at the DZNE. The scientists want to…
DZNE Ulm participates in two collaborative research centers with projects on Parkinson's
Prof. Karin Danzer, neuroscientist at the DZNE Ulm site, has received about 460,000 euros as a member of…
Hans and Ilse Breuer Foundation awards Alzheimer's doctoral fellowship 2023 to DZNE
In order to promote young scientists in the field of dementia research in Germany, the Frankfurt Hans and Ilse…
Contact
Dr. Janine Lücke janine.luecke@dzne.de
Diversity at DZNE
At the DZNE, we aim to use the full potential of society and research to understand neurodegenerative diseases, decipher their…
Portrait on WDR Lokalzeit: DZNE researcher Prof. Monique M.B. Breteler
Prof. Monique M.B. Breteler is Director of Population Health Research and head of the Rhineland Study. The renowned Dutch…
Welcome to our website, here you can inform yourself basically cookie-free.
We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.
